{"SPADE_UN_08075": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 7001924 B2", "Patent Link": "http://www.lens.org/lens/patent/US_7001924_B2", "Patent Type": "Granted Patent", "Publication Date": "2006-2-21", "Family Info": "EP1435932A2,EP1435932A4,US20030134904,WO2003024407A2,WO2003024407A3", "Patent Title": "Inhibitors of RNase P proteins as antibacterial compounds.", "Abstract": "The present invention features compounds useful for inhibiting RNase P activity. These compounds can be used as therapeutics for treating or preventing a variety of bacterial infections. The compounds belong to several classes including mono- and bis-guanylhydrazones, guanylhydrazone mimetics, and benzothiazolium compounds. Exemplary compounds are compounds of formula I: \nYâ€”(NRâ€²)kâ€”U1â€”(NRâ€³)Iâ€”Aâ€”(NR1)mâ€”U2â€”(NR2)nâ€”Zâ€ƒâ€ƒI with substituents as described herein."}], "Sequence Information": {"SPADE ID": "SPADE_UN_08075", "Sequence": "KRLLTARQFSAVFRLGLVIGKKNVKLAVQRNRLKRLIRESFRHNQETLDIVVIARKGLGELENPELHQQFG", "Sequence Length": 71, "Peptide Name": "Sequence 71 from Patent US 7001924", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "LRK", "Absent Amino Acids": "CMOUWY", "Basic Residues": 17, "Acidic Residues": 6, "Hydrophobic Residues": 30, "Polar Residues": 40, "Positive Residues": 17, "Negative Residues": 6, "Mass": 8248.6, "PI": 11.51, "Net Charge": 11, "Hydrophobicity": -0.37, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_18501", "Similarity": 1.0, "Sequence": "KRLLTARQFSRLGLVIGKKNVKLAVQRNRLKRLIRELDIVVLHQQF"}, {"SPADE_ID": "SPADE_UN_08068", "Similarity": 0.8028169014084507, "Sequence": "KNLLTPRHFKAVFRLGLVIGKKSVKLAVQRNRLKRLMRDSFRLNQQLLDIVIVARKGLGEIENPELHQHFG"}, {"SPADE_ID": "SPADE_UN_18494", "Similarity": 0.7391304347826086, "Sequence": "KRLLTPRHFKRLGLVIGKKSVKLAVQRNRLKRLMRDLDIVILHQHF"}]}}}